BULLFROG AI HOLDINGS, INC. Cost of Revenue
BULLFROG AI HOLDINGS, INC. (BFRG) reported Cost of Revenue of $5.20 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-14.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsAndServicesSold · last filed 2025-03-14
- BULLFROG AI HOLDINGS, INC. cost of goods and services sold for the quarter ending 2023-12-31 was $0.00.
- BULLFROG AI HOLDINGS, INC. cost of goods and services sold for the quarter ending 2023-09-30 was $5.20K.
- BULLFROG AI HOLDINGS, INC. cost of goods and services sold for fiscal 2023 was $5.20K, a 550.00% increase from fiscal 2022.
- BULLFROG AI HOLDINGS, INC. cost of goods and services sold for fiscal 2022 was $800.00.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $5.20K derived: sum of 2 quarters · filed 2025-03-14 | $5.20K 10-K · filed 2025-03-14 | |
| 2023-09-30 | $5.20K 10-Q · filed 2024-11-08 | $5.20K 10-Q · filed 2024-11-08 | ||
| 2022-12-31 | $800.00 10-K · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B |